Number of items: 10.
2024
Pennel, K. A.F. et al.
(2024)
JAK/STAT3 represents a therapeutic target for colorectal cancer patients with stromal-rich tumors.
Journal of Experimental and Clinical Cancer Research, 43,
64.
(doi: 10.1186/s13046-024-02958-4)
Shamis, S. A. K., Savioli, F., Ammar, A. , Al-Badran, S. S.F., Hatthakarnkul, P., Leslie, H. , Mallon, E., Jamieson, N. B. , McMillan, D. C. and Edwards, J.
(2024)
Spatial transcriptomic analysis of tumour with high and low CAIX expression in TNBC tissue samples using GeoMx™ RNA assay.
Histology and Histopathology: Cellular and Molecular Biology, 39,
pp. 177-200.
(doi: 10.14670/HH-18-655)
(PMID:37681672)
2023
Hatthakarnkul, P. et al.
(2023)
Protein expression of S100A2 reveals it association with patient prognosis and immune infiltration profile in colorectal cancer.
Journal of Cancer, 14(10),
pp. 1837-1847.
(doi: 10.7150/jca.83910)
(PMID:37476187)
(PMCID:PMC10355195)
2022
Hatthakarnkul, P., Quinn, J. A. , Ammar, A. , Lynch, G., Van Wyk, H. , McMillan, D. C. , Thuwajit, C. and Edwards, J.
(2022)
Molecular mechanisms of tumour budding and its association with microenvironment in colorectal cancer.
Clinical Science, 136(8),
pp. 521-535.
(doi: 10.1042/CS20210886)
(PMID:35445707)
2021
Abdullah, N. A., Md Hashim, N. F., Ammar, A. and Muhamad Zakuan, N.
(2021)
An insight into the anti-angiogenic and anti-metastatic effects of oridonin: current knowledge and future potential.
Molecules, 26(4),
775.
(doi: 10.3390/molecules26040775)
(PMID:33546106)
(PMCID:PMC7913218)
Hatthakarnkul, P., Quinn, J. A. , Matly, A. A. M., Ammar, A. , Van Wyk, H. C. , McMillan, D. C. and Edwards, J.
(2021)
Systematic review of tumour budding and association with common mutations in patients with colorectal cancer.
Critical Reviews in Oncology/Hematology, 167,
103490.
(doi: 10.1016/j.critrevonc.2021.103490)
(PMID:34619332)
2018
Ahmad, N., Ammar, A. , Storr, S., Green, A., Rakha, E., Ellis, I. and Martin, S.
(2018)
IL-6 and IL-10 are associated with good prognosis in early stage invasive breast cancer patients.
Cancer Immunology, Immunotherapy, 67(4),
pp. 537-549.
(doi: 10.1007/s00262-017-2106-8)
(PMID:29256156)
(PMCID:PMC5860102)
2014
Ammar, A. , Blal, M., Halabi, A. and Al-Shehabi, Z.
(2014)
A comparative immunohistochemical analysis of cathepsins B and S in human breast cancer.
Clinical Cancer Investigation Journal, 3(5),
pp. 388-393.
(doi: 10.4103/2278-0513.138056)
2011
Ammar, A. , Mohammed, R. A.A., Salmi, M., Pepper, M., Paish, E. C., Ellis, I. O. and Martin, S. G.
(2011)
Lymphatic expression of CLEVER-1 in breast cancer and its relationship with lymph node metastasis.
Analytical Cellular Pathology, 34(1-2),
pp. 67-78.
(PMID:21483103)
(PMCID:PMC4605559)
2009
Ahlskog, J.K.J., Schliemann, C., Mårlind, J., Qureshi, U., Ammar, A. , Pedley, R.B. and Neri, D.
(2009)
Human monoclonal antibodies targeting carbonic anhydrase IX for the molecular imaging of hypoxic regions in solid tumours.
British Journal of Cancer, 101(4),
pp. 645-657.
(doi: 10.1038/sj.bjc.6605200)
(PMID:19623173)
(PMCID:PMC2736829)
This list was generated on Sun Oct 6 16:40:36 2024 BST.